Research Group
Chemopreventive Agent Development
Sponsor
UCSF Benioff Children's Hospital Oakland
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00783965
RATIONALE: Drugs used in chemotherapy, such as tazarotene, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.
PURPOSE: This randomized phase II trial is comparing two different schedules of topical tazarotene and topical placebo to see how well they work in treating patients with basal cell skin cancer and basal cell nevus syndrome on the chest.
PURPOSE: This randomized phase II trial is comparing two different schedules of topical tazarotene and topical placebo to see how well they work in treating patients with basal cell skin cancer and basal cell nevus syndrome on the chest.
Intervention
tazarotene, placebo
Condition
Skin Carcinoma
Investigators
David R. Bickers, MD, Ervin Epstein, MD